Amanda Marie Mascarenas, ATC, CSCS | |
262 Crestwood Ln, Raeford, NC 28376-7828 | |
(540) 220-8171 | |
Not Available |
Full Name | Amanda Marie Mascarenas |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Sports Medicine |
Location | 262 Crestwood Ln, Raeford, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013598499 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083S0010X | Preventive Medicine - Sports Medicine | LAT-4149 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amanda Marie Mascarenas, ATC, CSCS 262 Crestwood Ln, Raeford, NC 28376-7828 Ph: (540) 220-8171 | Amanda Marie Mascarenas, ATC, CSCS 262 Crestwood Ln, Raeford, NC 28376-7828 Ph: (540) 220-8171 |
News Archive
METTLER TOLEDO is pleased to launch its Standard Line precision test weights. Produced according to ISO 9001 guidelines, all Standard Line weights conform to U.S. Food & Drug Administration standards and fulfill OIML R111 requirements to ensure measurements comply with applicable regulations.
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer - easing many of the negative effects of the disease on patients' quality of life.
Maternal and fetal outcomes are favorable for most pregnancies that reach 20 weeks' in women with chronic portal vein thrombosis, a study shows.
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA.
Increasing the testosterone levels of female cancer survivors using testosterone cream did not improve their libido more than a placebo, according to a randomized controlled clinical trial in the May 2 Journal of the National Cancer Institute.
› Verified 4 days ago